Last updated on April 2018

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

Brief description of study

Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System in combination with standard of care radiation therapy and temozolomide for the treatment of newly diagnosed glioblastomas (GBM).

Clinical Study Identifier: NCT02880410

Contact Investigators or Research Sites near you

Start Over

Cleveland Clinic Foundation
Cleveland, OH United States

Washington University
Saint Louis, MO United States

Wake Forest Baptist Health
Winston-Salem, NC United States

MD Anderson Cancer Center
Houston, TX United States